Fast Facts: Biosimilars in Hematology and Oncology : Biologics and biosimilars - getting decisions right
Biologics have revolutionized - and are revolutionizing - the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars...
Đã lưu trong:
| Những tác giả chính: | , |
|---|---|
| Định dạng: | Livre numérique |
| Ngôn ngữ: | Anglais |
| Được phát hành: |
Basel :
S. Karger
2020.
Basel : |
| Truy cập trực tuyến: | https://www.karger.com/Book/Home/279159 Accès Université d'Orléans et IFPM |
| Chú thích: |
Karger Fast Facts |
| Autres localisations: | Voir dans le Sudoc |
| Edition sous un autre format: | • Fast Facts: Biosimilars in Hematology and Oncology, 9781912776214 |
| LEADER | 01821nam a22002297a 4500 | ||
|---|---|---|---|
| 001 | 1326079 | ||
| 008 | 230208s2020 xx ||| |||| 00| 0 eng d | ||
| 009 | PPN267639864 | ||
| 020 | |a 9781912776221 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Cornes, Paul. | |
| 245 | 1 | 0 | |a Fast Facts: Biosimilars in Hematology and Oncology : |b Biologics and biosimilars - getting decisions right |c Paul Cornes ; Ali McBride. |
| 260 | |a Basel : |b S. Karger. | ||
| 260 | |a Basel : |b S. Karger, |c 2020. | ||
| 500 | |a Karger Fast Facts | ||
| 506 | |a Accès libre pour tout établissement ou utilisateur ayant un compte sur la plateforme de l'éditeur | ||
| 520 | |a Biologics have revolutionized - and are revolutionizing - the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars - particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Fast Facts: Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients. | ||
| 700 | 1 | |a McBride, Ali. |4 aut | |
| 776 | 0 | |t Fast Facts: Biosimilars in Hematology and Oncology |z 9781912776214 | |
| 856 | 4 | |u https://www.karger.com/Book/Home/279159 | |
| 856 | 4 | |5 452349901:858581469 |u https://ezproxy.univ-orleans.fr/login?url=https://www.karger.com/Book/Home/279159 |z Accès Université d'Orléans et IFPM | |
| 997 | |0 1326079 |1 Livre numérique |a Ressource numérique |b INSA |b ENSA |c 0/Bibliothèque numérique/ |c 1/Bibliothèque numérique/Autre ressource numérique/ | ||